Skip to main content
. 2014 Mar 14;122(6):616–623. doi: 10.1289/ehp.1307201

Table 4.

ORs (95% CIs) of incident T2D by quartiles of urinary concentrations of BPA according to the menopausal status of cases: the NHS and NHSII.

Menopausal status at diabetes diagnosis Quartile 1 (lowest) Quartile 2 Quartile 3 Quartile 4 (highest) ptrend pinteraction
Premenopause
Case/control (n) 39/45 54/55 77/79 80/71
Model 1a 1.0 2.53 (0.82, 7.76) 3.39 (1.14, 10.09) 5.83 (1.68, 20.19) 0.01 0.03
Postmenopause
Case/control (n) 194/197 191/188 162/162 174/172
Model 1a 1.0 0.85 (0.59, 1.23) 0.85 (0.57, 1.27) 0.83 (0.54, 1.27) 0.50
aAdjusted for matching factors, BMI, smoking status, postmenopausal hormone use (NHS only), oral contraceptive use (NHSII only), physical activity, alcohol use, family history of diabetes, history of hypercholesterolemia or hypertension, urinary creatinine levels, and AHEI score.
HHS Vulnerability Disclosure